Breast cancer activists in the 90s got DOD to fund cancer research—now that program has been gutted

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In 1991, the National Breast Cancer Coalition demanded that the federal government spend $300 million more on breast cancer research. This push resulted in the creation of the Department of Defense Congressionally Directed Medical Research Program, which has broadened to 34 other diseases with an FY24 budget of $1.5 billion.

Now, 33 years later, through the continuing resolution passed March 14, funding for CDMRP was cut by 57%, compared to FY24 levels.

CDMPR slashed more than half of its programs, leaving only 12 programs funded in FY25.

The Breast Cancer Research Program is facing a $20 million cut, dropping from $150 million in FY24 to $130 million in FY25.

A story about the funding cut can be found in this issue. 

Back in 1991, professional societies, NIH, and NCI deemed $300 million in breast cancer research funding “an outlandish figure.” Still, NBCC continued to push for the funding.

By routing the money through DOD, a new—and sometimes controversial—research program was born. Some argued, particularly within NIH, that this funding should follow more traditional and established pathways. The Cancer Letter tracked the ensuing turf war in real time, all the way to NBCC’s victory and, later, the victory of other patient advocates.

They didn’t do it by simply, politely, and softly knocking on a door and saying, ‘If you wouldn’t mind.’ They did it by laying a case for why they needed more money, and then demanding that, and collaborating with scientists to make certain that message got through to Congress.

Fran Visco

How 1960s activism shaped the movement that resulted in the DOD breast cancer program
By the Cancer History Project, Sept. 10, 2021 

Fran Visco never asked for $300 million in breast cancer research funding—she demanded it.

An activist of the 1960s, Visco, president of the National Breast Cancer Coalition, changed the landscape of funding for breast cancer research during her 1992 testimony in front of Congress.

“We took a lesson from AIDS activists, and we made a case for why $300 million more was the right number,” Visco said to The Cancer Letter. “They didn’t do it by simply, politely, and softly knocking on a door and saying, ‘If you wouldn’t mind.’ They did it by laying a case for why they needed more money, and then demanding that, and collaborating with scientists to make certain that message got through to Congress.”

At the time, professional societies, NIH, and NCI deemed $300 million in breast cancer research funding “an outlandish figure.”

Visco wasn’t going to achieve NBCC’s goal by going the traditional route of snooze-worthy testimony. She realized this on the train to Washington from Philadelphia, where she was unimpressed with the prepared remarks from NBCC.

“It was very traditional testimony about why we needed more money for breast cancer research,” she said. “I’m an activist from the sixties, women’s rights, anti-war. It just didn’t ring well with me.”

On the train, Visco revised these remarks. “To sit there and just politely ask ‘If you wouldn’t mind,’ that was not my world.”

The testimony itself was for what was known as “Disease Day” on Capitol Hill. “Organization after organization [was] going up and asking for money for research, for their particular issue,” Visco recalled recently. “It was all very polite. It was: ‘We understand that it’s difficult, but if you could see your way through, we would like level funding.’”

A full conversation with Visco is available on the Cancer History Project.

Advocacy in Action: The DOD Breast Cancer Research Program 
By National Breast Cancer Coalition, Sept. 2, 2021

At first glance, the Department of Defense and breast cancer research might not seem like an easy or natural fit.

And that’s just how the National Breast Cancer Coalition (NBCC) would have it. NBCC is an organization that pushes against the status quo, so finding innovative solutions to complicated problems is a hallmark of their work. The Department of Defense Breast Cancer Research Program (DOD BCRP) is an example of how NBCC advocates pushed boundaries to pursue critical research funding and changes to the system of research that incorporate advocates and support meaningful results.

Understanding that significant federal funding would be a requirement to make meaningful progress in the fight to end breast cancer, in 1991, NBCC conducted a “$300 Million More Campaign”, which called on Congress to fund breast cancer research. Advocates from across the country voiced their support and despite pushback from some Members of Congress, and a challenging legislative process, NBCC persevered. In response to NBCC’s campaign in 1992, the Department of Defense Breast Cancer Research Program (DOD BCRP) was established.

Read more

Video: An Armchair Discussion with Fran Visco on NBCC’s History
By National Breast Cancer Coalition, Sept. 7, 2022

The National Breast Cancer Coalition’s 2022 Advocate Leadership Summit included a special armchair discussion with NBCC president Fran Visco. Paul Goldberg, editor and publisher of The Cancer Letter sat down with Fran to interview her about NBCC’s history.

Watch the video on the Cancer History Project.

Selected coverage in The Cancer Letter


This column features the latest posts to the Cancer History Project by our growing list of contributors

The Cancer History Project is a free, web-based, collaborative resource intended to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The objective is to assemble a robust collection of historical documents and make them freely available. 

Access to the Cancer History Project is open to the public at CancerHistoryProject.com. You can also follow us on Twitter at @CancerHistProj, or follow our podcast.

Is your institution a contributor to the Cancer History Project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key organizations in oncology. 

To apply to become a contributor, please contact admin@cancerhistoryproject.com.

Table of Contents

YOU MAY BE INTERESTED IN

Breast cancer surgeon Tari A. King was appointed as chief surgical officer for the cancer service line at Winship Cancer Institute of Emory University and Emory Healthcare. Joining Emory on July 14, she will also be the chief of the newly formed Division of Breast Surgery in the Department of Surgery at Emory University School of Medicine and co-director of Winship’s Glenn Family Breast Center.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login